Let's Find Opportunities Overseas

Tag: Funanc1al Turnaround Plays

Teva Pharmaceuticals stock price on a monitor, with prescription pills and an Israeli flag in the background—symbolizing resurgence and hedge fund interest in TEVA stock.

Teva Pharma: The Funds Believe. Should You?

Hedge fund legend Stanley Druckenmiller just upped his stake in TEVA by 65%—and he’s not alone. With 9 straight quarters of growth, rising biosimilar momentum, and a “Pivot to Growth” strategy in motion, Teva might finally be ready for its rerating. We still like the sandals, but the stock may be worth more than a hike.

Read entire article

Tags: Biosimilars, BiotechStocks, DeepValue, Druckenmiller, Funanc1al, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al International Investment Series, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alInsiders, Funanc1alInsiderSeries, Funanc1alInternational, Funanc1alStocks, GenericDrugs, HedgeFundBuys, InsiderBuying, IsraelStocks, PharmaInvesting, TEVA, ValueInvesting